Isabelle Kenyon

Isabelle Kenyon is the Founder & CEO of Calibrate, a metabolic health company on a mission to change the way the world treats weight. In two years, Calibrate raised more than $125 million from leading investors, including Founders Fund, Tiger Global, Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health, and has published clinically-reviewed results from its Metabolic Reset that exceeded clinical trial outcomes across metabolic markers. Calibrate was designated as a World Economic Forum Technology Pioneer in 2021. In 2022, Calibrate launched its enterprise business starting with self-insured employers and was named the Employer Health Innovation Roundtable Traction Award Winner. Additionally, Calibrate’s Metabolic Reset was recognized by Fast Company’s World Changing Ideas and TIME’s Best Inventions in 2022.

Prior to Calibrate, Isabelle led business operations, growth, and strategic partnerships & communications at Capsule, a technology business rebuilding the pharmacy from the inside out. Before Capsule, she worked at beloved consumer brands in London and New York. Isabelle began her career as an investment banker in Hong Kong and graduated from the University of Pennsylvania. She was selected for the Forbes 30 Under 30 list in 2015 and named to Goldman Sachs’ Builders & Innovators in 2022. Isabelle additionally serves as the Advocacy Chair for Success Academy Charter School’s Young Professionals Committee.

Most Popular

Why obesity must be treated as the root of cardiometabolic disease